Literature DB >> 17024227

Sustained JNK signaling by proteolytically processed HPK1 mediates IL-3 independent survival during monocytic differentiation.

R Arnold1, C R Frey, W Müller, D Brenner, P H Krammer, F Kiefer.   

Abstract

We studied monocytic differentiation of primary mouse progenitor cells to understand molecular mechanisms of differentiation. We found a tightly controlled non-apoptotic activation of caspase-3 that correlated with differentiation. Although caspase activity was already detected during monocytic differentiation, a caspase-3 target has not been identified yet. We show that hematopoietic progenitor kinase 1 (HPK1) is processed towards its N- and C-terminal fragments during monocytic differentiation. While HPK1 is an immunoreceptor-proximal kinase in T and B cells, its role in myeloid cells is elusive. Here, we show that the N-terminal cleavage product, HPK1-N, comprising the kinase domain, confers progenitor cell survival independent of the growth factor IL-3. Furthermore, HPK1-N causes differentiation of progenitor cells towards the monocytic lineage. In contrast to full-length kinase, HPK1-N is constitutively active causing sustained JNK activation, Bad phosphorylation and survival. Blocking of caspase activity during differentiation of primary mouse progenitor cells leads to reduced HPK1-N levels, suppressed JNK activity and attenuated monocytic differentiation. Our work explains growth factor-independent survival during monocytic differentiation by caspase-mediated processing of HPK1 towards HPK1-N.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17024227     DOI: 10.1038/sj.cdd.4402042

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  11 in total

Review 1.  The regulatory crosstalk between kinases and proteases in cancer.

Authors:  Carlos López-Otín; Tony Hunter
Journal:  Nat Rev Cancer       Date:  2010-03-19       Impact factor: 60.716

2.  Dual role of hematopoietic progenitor kinase 1 (HPK1) as a positive regulator of 1α,25-dihydroxyvitamin D-induced differentiation and cell cycle arrest of AML cells and as a mediator of vitamin D resistance.

Authors:  Xiangwen Chen-Deutsch; George P Studzinski
Journal:  Cell Cycle       Date:  2012-04-01       Impact factor: 4.534

Review 3.  Regulation of monocyte differentiation by specific signaling modules and associated transcription factor networks.

Authors:  René Huber; Daniel Pietsch; Johannes Günther; Bastian Welz; Nico Vogt; Korbinian Brand
Journal:  Cell Mol Life Sci       Date:  2013-03-24       Impact factor: 9.261

4.  Protein kinase R as mediator of the effects of interferon (IFN) gamma and tumor necrosis factor (TNF) alpha on normal and dysplastic hematopoiesis.

Authors:  Bhumika Sharma; Jessica K Altman; Dennis J Goussetis; Amit K Verma; Leonidas C Platanias
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

5.  The pan-caspase inhibitor Q-VD-OPh has anti-leukemia effects and can interact with vitamin D analogs to increase HPK1 signaling in AML cells.

Authors:  Xiangwen Chen-Deutsch; Andrzej Kutner; Jonathan S Harrison; George P Studzinski
Journal:  Leuk Res       Date:  2012-04-26       Impact factor: 3.156

6.  Phosphorylation of CARMA1 by HPK1 is critical for NF-kappaB activation in T cells.

Authors:  Dirk Brenner; Markus Brechmann; Simone Röhling; Myriam Tapernoux; Thomas Mock; Dominic Winter; Wolf D Lehmann; Friedemann Kiefer; Margot Thome; Peter H Krammer; Rüdiger Arnold
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-11       Impact factor: 11.205

Review 7.  Caspases and kinases in a death grip.

Authors:  Manabu Kurokawa; Sally Kornbluth
Journal:  Cell       Date:  2009-09-04       Impact factor: 41.582

8.  Pro- and anti-apoptotic CD95 signaling in T cells.

Authors:  Maren Paulsen; Ottmar Janssen
Journal:  Cell Commun Signal       Date:  2011-04-08       Impact factor: 5.712

Review 9.  A perspective on HPK1 as a novel immuno-oncology drug target.

Authors:  Sansana Sawasdikosol; Steven Burakoff
Journal:  Elife       Date:  2020-09-08       Impact factor: 8.140

10.  Prognostic Value of mRNA Expression of MAP4K Family in Acute Myeloid Leukemia.

Authors:  Zhenjie Bai; Qingmei Yao; Zhongyi Sun; Fang Xu; Jicheng Zhou
Journal:  Technol Cancer Res Treat       Date:  2019-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.